Consulter en ligne

Suggestions

Du même auteur

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis

Archive ouverte | Amato, Anthony | CCSD

International audience. Objective To assess long-term (2 years) effects of bimagrumab in participants with sporadic inclusion body myositis (sIBM). Methods Participants (aged 36–85 years) who completed the core stud...

Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial

Archive ouverte | Hanna, Michael | CCSD

International audience

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

Archive ouverte | Aggarwal, Rohit | CCSD

Auteurs : the International Myositis Assessment and Clinical Studies Group (IMACS) and the Paediatric Rheumatology International Trials Organisation (PRINTO. International audience

Chargement des enrichissements...